Armata Pharmaceuticals, Inc.
ARMP
DELAYED 1 MONTH

10 insider filings · Latest: Mar 14, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 9, 2026Mar 12 1:18 AMRobin KramerDirector
Grant/Award
25,640$11.6125,640(D)

View →

Mar 9, 2026Mar 12 1:18 AMPierre KymeChief Business Officer
Grant/Award
183,142$11.61183,142(D)

View →

Mar 9, 2026Mar 12 1:17 AMDavid Duane HouseSVP, Finance, and PFO
Grant/Award
109,885$11.61109,885(D)

View →

Mar 9, 2026Mar 12 1:17 AMJoseph M PattiDirector
Grant/Award
25,640$11.6125,640(D)

View →

Mar 9, 2026Mar 12 1:16 AMTodd C. PetersonDirector
Grant/Award
25,640$11.6125,640(D)

View →

Mar 9, 2026Mar 12 1:15 AMKostas D OdysseasDirector
Grant/Award
25,640$11.6125,640(D)

View →

Mar 9, 2026Mar 12 1:15 AMDeborah BirxDirector, Chief Executive Officer
Grant/Award
421,226$11.61421,226(D)

View →

Mar 9, 2026Mar 12 1:14 AMSarah J. SchlesingerDirector
Grant/Award
25,640$11.6125,640(D)

View →

Mar 9, 2026Mar 12 1:13 AMJules HaimovitzDirector
Grant/Award
25,640$11.6125,640(D)

View →